| Literature DB >> 22396914 |
Pierre Marie Kaktcham1, Ngoufack François Zambou, Félicité Mbiapo Tchouanguep, Morsi El-Soda, Muhammad Iqbal Choudhary.
Abstract
Twenty-one Lactobacillus isolates from "Sha'a" (a maize - based fermented beverage) and "Kossam" (traditionally fermented cow milk) were selected in accordance with their antagonistic activities and tested for their bacteriocinogenic potential as well as safety properties. These isolates were preliminarily identified as Lactobacillus plantarum (62%), Lactobacillus rhamnosus (24%), Lactobacillus fermentum (10%) and Lactobacillus coprophilus (4%) based on phenotypic characteristics and rep-PCR genomic fingerprinting. Twelve (57.1%) out of the 21 strains tested were found to be bacteriocin producers, as revealed by the sensitivity of their antimicrobial substances to proteolytic enzymes (Trypsin, Proteinase K) and inhibition of other Lactobacillus spp. These bacteriocinogenic strains showed no positive haemolytic and gelatinase activities and proved to be sensitive to penicillin G, ampicillin, tetracycline, erythromycin, amoxicillin, chloramphenicol, co-trimoxazole and doxycyclin, but resistant to ciprofloxacin and gentamicin. The bacteriocins showed a broad inhibitory activity against Gram-positive and Gram-negative pathogenic bacteria, several of which are classified as especially dangerous by the World Health Organization, as well as Multidrug-resistant strains. These include Staphylococcus aureus, Salmonella enterica subsp. enterica serovare Typhi, Bacillus cereus, Streptococcus mutans, Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae and Shigella flexneri. These Lactobacillus strains are promising candidates for use as protective cultures in food fermentation.Entities:
Keywords: Antimicrobial activity; Kossam; Lactobacillus spp.; Rep-PCR; Safety properties; Sha’a
Year: 2011 PMID: 22396914 PMCID: PMC3293358 DOI: 10.3797/scipharm.1107-12
Source DB: PubMed Journal: Sci Pharm ISSN: 0036-8709
Comparison of the identification of Lactobacilli isolates using API system and rep-PCR profiles.
| Isolates | Identification by API system (% similarity) | Identification by rep-PCR (% identity) |
|---|---|---|
…API result does not match with rep-PCR identification in this case.
Fig. 1Dendrograms generated from Box-PCR fingerprinting of the isolated Group II and Group III Lactobacillus spp. The dendrogram was constructed using the unweighted pair group method using arithmetic averages with correlation levels expressed as percentage.
Effect of proteolytic and non-proteolytic enzymes on the activity of cell free supernatants.
| Mean Inhibition Zone diameter (mm) | ||||||
|---|---|---|---|---|---|---|
|
| ||||||
| Strains | Control | Trypsin | Proteinase K | α-Amylase | Lipase | Lysozyme |
| 12.5 | 0 (−) | 0 (−) | 12 (+) | 12.5 (+) | 12.5 (+) | |
| 13.5 | 0 (−) | 0 (−) | 13.5 (+) | 13.5 (+) | 13.5 (+) | |
| 16 | 0 (−) | 0 (−) | 15.5 (+) | 15.5 (+) | 16 (+) | |
| 13 | 0 (−) | 0 (−) | 12.5 (+) | 12.5 (+) | 12.5 (+) | |
| 12.5 | 0 (−) | 0 (−) | 12.5 (+) | 12.5 (+) | 12.5 (+) | |
| 13 | 0 (−) | 0 (−) | 13 (+) | 13 (+) | 13 (+) | |
| 8 | 0 (−) | 0 (−) | 8 (+) | 8 (+) | 8 (+) | |
| 13 | 0 (−) | 9 (+) | 13 (+) | 13 (+) | 13 (+) | |
| 12 | 0 (−) | 0 (−) | 12 (+) | 12 (+) | 12 (+) | |
| 12 | 0 (−) | 0 (−) | 12 (+) | 12 (+) | 12 (+) | |
| 14 | 0 (−) | 0 (−) | 14 (+) | 14 (+) | 14 (+) | |
| 13 | 0 (−) | 0 (−) | 13 (+) | 13 (+) | 13 (+) | |
…Inhibition zone diameters are means of three assays and include the diameter of the wells (6 mm).
Fig. 2Antimicrobial activity assessed by halo formation of bacteriocin from strain Lb. plantarum 6S treated with enzymes.
C1: CFS in Tris-HCl buffer, pH 8.0 (untreated).
C: CFS in Phosphate buffer, pH 7.0 (untreated).
T: CFS treated with Trypsin (1 mg/ml).
A: CFS treated with α-Amylase (1 mg/ml).
Li: CFS treated with Lipase (1 mg/ml).
Ly: CFS treated with Lysozyme (1 mg/ml).
Susceptibility of Lactobacillus strains to antibiotics by disc diffusion test
| Inhibition Diameters (mm) | |||||
|---|---|---|---|---|---|
|
| |||||
| Strains | AMP10 | ERY15 | PEN10 | CHL30 | TET30 |
| 28 (S) | 30 (S) | 23 (S) | 22 (S) | 22 (S) | |
| 31 (S) | 27 (S) | 22 (S) | 20 (I) | 20 (I) | |
| 30 (S) | 30 (S) | 23 (S) | 25 (S) | 26 (S) | |
| 28 (S) | 30 (S) | 27 (S) | 25 (S) | 23 (S) | |
| 31 (S) | 28 (S) | 30 (S) | 37 (S) | 22 (S) | |
| 34 (S) | 30 (S) | 25 (S) | 25 (S) | 25 (S) | |
| 28 (S) | 26 (S) | 21 (S) | 25 (S) | 20 (I) | |
| 28 (S) | 27 (S) | 22 (S) | 25 (S) | 18 (I) | |
| 27 (S) | 27 (S) | 20 (I) | 27 (S) | 22 (S) | |
| 35 (S) | 30 (S) | 22 (S) | 27 (S) | 29 (S) | |
| 35 (S) | 32 (S) | 24 (S) | 22 (S) | 25 (S) | |
| 27 (S) | 28 (S) | 26 (S) | 25 (S) | 21 (S) | |
|
| |||||
|
| |||||
|
| |||||
| 13 (R) | 13 (R) | 30 (S) | 22 (S) | 21 (S) | |
|
| |||||
| 13 (R) | 7 (R) | 30 (S) | 17 (I) | 20 (I) | |
|
| |||||
| 11 (R) | 10 (R) | 28 (S) | 20 (I) | 26 (S) | |
|
| |||||
| 12 (R) | 12 (R) | 30 (S) | 22 (S) | 22 (S) | |
|
| |||||
| 14 (R) | 12 (R) | 28 (S) | 25 (S) | 24 (S) | |
|
| |||||
| 22 (S) | 14 (R) | 33 (S) | 20 (I) | 29 (S) | |
|
| |||||
| 16 (I) | 7 (R) | 25 (S) | 23 (S) | 23 (S) | |
|
| |||||
| 18 (I) | 12 (R) | 26 (S) | 21 (S) | 25 S) | |
|
| |||||
| 14 (R) | 11 (I) | 28 (S) | 20 (I) | 25 (S) | |
|
| |||||
| 21 (S) | 14 (R) | 32 (S) | 18 (I) | 28 (S) | |
|
| |||||
| 20 (I) | 15 (R) | 29 (S) | 16 (I) | 26 (S) | |
|
| |||||
| 16 (I) | 11 (R) | 25 (S) | 24 (S) | 26 (S) | |
AMO10: Amoxicillin 10μg; AMP10: Ampicillin 10μg; COT25: Co-trimoxazole (Trimethoprim/Sulfamethoxazole) 1.25+23.75= 25μg; CHL30: Chloramphenicol 30μg; CIP10: Ciprofloxacin 10 μg; DOX30: Doxycyclin 30μg; ERY15: Erythromycin 15μg; PEN10: Penicillin G 10μg; TET30: Tetracycline 30 μg; GEN30: Gentamicin 30μg (CLSI, 2011).
…Inhibition Zone Diameters are means from triplicate determinations; Diameters of the discs are inclusive (6mm); S…Sensitive; I…Intermediate; R…Resistant.
MIC values (in μg/ml) of antibiotics against Lactobacillus strains.
| Strains | AMP | PEN | ERY | CHL | TET | |||||
|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||
| MIC μg/ml | MIC BP | MIC μg/ml | MIC BP | MIC μg/ml | MIC BP | MIC μg/ml | MIC BP | MIC μg/ml | MIC BP | |
| 0.5 | 2 | 2 | ND | <0.25 | 1 | 2 | 8 | 8 | 32 | |
| 0.5 | 2 | 2 | ND | <0.25 | 1 | 2 | 8 | 8 | 32 | |
| 0.5 | 2 | 1 | ND | <0.25 | 1 | 2 | 8 | 8 | 32 | |
| 0.5 | 2 | 1 | ND | <0.25 | 1 | 2 | 8 | 16 | 32 | |
| 1 | 2 | 2 | ND | <0.25 | 1 | 2 | 8 | 8 | 32 | |
| 1 | 2 | 1 | ND | <0.25 | 1 | 4 | 8 | 16 | 32 | |
| 0.5 | 2 | 1 | ND | <0.25 | 1 | 2 | 8 | 8 | 32 | |
| 0.5 | 2 | 1 | ND | <0.25 | 1 | 4 | 8 | 8 | 32 | |
| 0.5 | 2 | 1 | ND | <0.25 | 1 | 2 | 8 | 16 | 32 | |
| 0.5 | 4 | 1 | ND | <0.25 | 1 | 2 | 4 | 8 | 8 | |
| 0.5 | 4 | 2 | ND | <0.25 | 1 | 2 | 4 | 16 | 8 | |
| 0.5 | 1 | 1 | ND | <0.25 | 1 | 2 | 4 | 8 | 8 | |
|
| ||||||||||
|
| ||||||||||
| MIC μg/ml | MIC BP | MIC μg/ml | MIC BP | MIC μg/ml | MIC BP | MIC μg/ml | MIC BP | MIC μg/ml | MIC BP | |
|
| ||||||||||
| 64 | 16 | 1 | ND | 64 | ND | 32 | ND | 1 | ND | |
| 64 | 16 | 0.5 | ND | 128 | ND | 32 | ND | 2 | ND | |
| 64 | 16 | 1 | ND | 64 | ND | 32 | ND | 2 | ND | |
| 64 | 16 | 0.5 | ND | 64 | ND | 64 | ND | 4 | ND | |
| 64 | 16 | 0.5 | ND | 64 | ND | 64 | ND | 4 | ND | |
| 64 | 16 | 1 | ND | 64 | ND | 64 | ND | 4 | ND | |
| 32 | 16 | 0.5 | ND | 128 | ND | 64 | ND | 4 | ND | |
| 64 | 16 | 0.5 | ND | 64 | ND | 32 | ND | 4 | ND | |
| 64 | 16 | 2 | ND | 64 | ND | 32 | ND | 4 | ND | |
| 64 | 16 | 0.5 | ND | 64 | ND | 32 | ND | 4 | ND | |
| 64 | 16 | 0.5 | ND | 64 | ND | 64 | ND | 4 | ND | |
| 64 | 16 | 0.5 | ND | 64 | ND | 64 | ND | 2 | ND | |
MIC BP = Minimal Inhibitory Concentration Breakpoints, according to European Food Safety Authorities [5]. ND…Not Defined.
Antibacterial spectrum of activity of bacteriocins produced by selected strains.
| Bacteriocin Activity of Producer strains | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||||||
| Indicator strains | Source | Growth conditions | 2S | 5S | 6S | 7S | 8S | 9S | 10S | 11S | 16S | 18S | 1K | 2K |
|
| ||||||||||||||
| Our isolate | MRS | ++ | ++ | +++ | ++ | ++ | ++ | + | ++ | ++ | ++ | ++ | ++ | |
| Our isolate | MRS,30°C | − | − | − | − | − | − | − | − | − | − | − | − | |
| Our collection | MRS,30°C | − | − | − | − | − | − | − | − | − | − | − | − | |
| Our isolate | MRS,30°C | − | − | − | − | − | − | − | − | − | − | − | − | |
| Our isolate | MRS,30°C | − | − | − | − | − | − | − | − | − | − | − | − | |
| Our isolate | MRS,30°C | − | − | − | − | − | − | − | − | − | − | − | − | |
| DSM | BHI | − | − | − | − | − | − | − | − | − | − | − | − | |
|
| ||||||||||||||
|
| ||||||||||||||
| ATCC 25923 | BHI, 37°C | ++ | ++ | ++ | ++ | ++ | ++ | ++ | ++ | ++ | ++ | ++ | ++ | |
| Clinical isolate | BHI, 37°C | ++ | ++ | ++ | ++ | ++ | ++ | ++ | ++ | ++ | ++ | ++ | ++ | |
| ATCC 11778 | BHI, 37°C | ++ | ++ | ++ | ++ | ++ | ++ | ++ | ++ | ++ | ++ | ++ | ++ | |
| DSM 20523 | BHI, 37°C | ++ | +++ | +++ | ++ | ++ | ++ | ++ | ++ | +++ | ++ | +++ | +++ | |
|
| ||||||||||||||
|
| ||||||||||||||
| ATCC 11775 | BHI, 37°C | ++ | ++ | ++ | ++ | ++ | +++ | ++ | ++ | ++ | ++ | ++ | ++ | |
| Clinical isolate | BHI, 37°C | − | − | + | − | − | − | − | − | − | − | ++ | − | |
| ATCC 6539 | NBe, 37°C | +++ | +++ | +++ | ++ | +++ | +++ | +++ | +++ | +++ | +++ | +++ | +++ | |
| ATCC 9027 | BHI, 37°C | +++ | ++ | +++ | +++ | ++ | ++ | ++ | ++ | +++ | ++ | +++ | ++ | |
| ATCC 27853 | BHI, 37°C | ++ | ++ | ++ | ++ | ++ | ++ | ++ | ++ | ++ | ++ | ++ | ++ | |
| Clinical isolate | BHI, 37°C | ++ | ++ | +++ | ++ | ++ | ++ | ++ | ++ | +++ | ++ | ++ | ++ | |
| Clinical isolate | NB, 37°C | + | + | ++ | ++ | ++ | +++ | ++ | ++ | +++ | ++ | ++ | +++ | |
Inhibition zone Diameter: +++ = >14mm; ++ = 11–14mm; + = 8–10mm; − = no inhibition. MDR: Multidrug-resistant;
DSM: Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, Braunschweig, Germany;
ATCC: American Type Culture Collection, Manassas, VA, USA;
de Man, Rogosa and Sharpe;
Brain Heart Infusion;
Nutrient Broth;
Isolates from Centre Pasteur of Yaoundé, Cameroon.